ACCELERATE

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

More Information

Trial Status
Accepting patients
Trial Phase
Phase 2
Enrollment
358 patients (estimated)
Tags
Allogeneic Stem Cell Transplant
Trial Type
Treatment
Last Update
SparkCures ID
2222
NCT Identifier
NCT06859424

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 803-1766

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.